[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1982

Hemodynamics of Intravenous Nitroglycerin During Aortic Clamping

Author Affiliations

From the Departments of Anesthesiology (Dr Zaidan, Ms Guffin, and Mr McNeill) and Surgery (Dr Perdue), Emory University Hospital and the Department of Surgery, Veterans Administration Hospital (Dr Smith), Atlanta.

Arch Surg. 1982;117(10):1285-1288. doi:10.1001/archsurg.1982.01380340021006
Abstract

• Anesthetic management and dosage schedules of vasodilators have not been standardized in many studies of aortic cross clamping (CCL). For this reason, 25 consecutive patients with arteriosclerotic disease of the aorta were studied, all having received the same anesthetic management. Six patients who received nitroglycerin during the cross clamp period, at a dosage of 0.25 μg/kg/min, were compared with 19 who underwent CCL without the drug. Contractility was maintained in the nitroglycerin group, but not in the other group. Despite a low cardiac index in both groups, peripheral blood flow was adequate only in the nitroglycerin group. Intrapulmonary shunt was higher in the nitroglycerin group, but it did not significantly decrease the Pao2. Nitroglycerin infusion seems to be helpful in maintaining pre-CCL contractility and adequacy of peripheral blood flow.

(Arch Surg 1982;117:1285-1288)

×